A0A6D2XCX3 (A0A6D2XCX3_PONAB) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)
Oxidized purine nucleoside triphosphate hydrolase UniProtKBInterProInteractive Modelling
156 aa; Sequence (Fasta) ;
1 identical sequence: Homo sapiens: P36639
It is possible new templates exist for this target since these models were created.
Available Structures
107 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| MTH1 in complex with TH013071 | homo-2-mer | 100 | 2×KYI; 1×ACT; 6×SO4; | |||
| Crystal structure of NUDT1 (MTH1) with S-crizotinib | homo-2-mer | 100 | 2×VHS; 2×CL; 10×SO4; | |||
| Crystal structure of NUDT1 (MTH1) with R-crizotinib | homo-2-mer | 100 | 2×CL; 2×VGH; 10×SO4; | |||
| Crystal structure of human MTH1(G2K/C87A/C104S mutant) in complex with 2-oxo-dATP | monomer | 98.08 | 1×6U4; 2×NA; | |||
| Crystal structure of human MTH1(G2K/C87A/C104S mutant) in complex with 8-oxo-dGTP determined using … | monomer | 98.08 | 1×8DG; 3×NA; 2×GOL; | |||
| Crystal structure of human MTH1(G2K mutant) in complex with 2-oxo-dATP at pH 8.6 | monomer | 99.35 | 1×6U4; 4×NA; | |||
| Crystal structure of human MTH1(G2K/D120N mutant) in complex with 2-oxo-dATP at pH 9.7 | monomer | 98.72 | 1×6U4; 2×NA; | |||
| Crystal structure of human MTH1(G2K mutant) in complex with 8-oxo-dGTP at pH 7.7 | monomer | 99.36 | 1×8DG; 2×NA; | |||
| Crystal structure of human MTH1(G2K mutant) in complex with 2-oxo-dATP at pH 8.0 | monomer | 99.36 | 1×6U4; 3×NA; | |||
| Crystal structure of human MTH1(G2K mutant) in complex with 2-oxo-dATP at pH 9.1 | monomer | 99.35 | 1×6U4; 2×NA; 1×GOL; | |||
| Crystal structure of human MTH1(G2K mutant) in complex with 2-oxo-dATP at pH 9.7 | monomer | 99.35 | 2×NA; 1×GOL; | |||
| Crystal structure of human MTH1(G2K/D120A mutant) in complex with 2-oxo-dATP under high concentrati… | monomer | 98.72 | 1×6U4; 2×NA; | |||
| Crystal structure of human MTH1(G2K/D120A mutant) in complex with 8-oxo-dGTP | monomer | 98.72 | 1×GOL; 1×NA; | |||
| Crystal structure of human MTH1(G2K/D120A mutant) in complex with 2-oxo-dATP | monomer | 98.72 | 1×NA; | |||
| Crystal structure of human MTH1(G2K/D120N mutant) in complex with 2-oxo-dATP at pH 7.7 | monomer | 98.72 | 1×6U4; 2×NA; | |||
| Crystal structure of human MTH1(G2K mutant) in complex with 2-oxo-dATP | monomer | 99.36 | 1×6U4; 2×NA; | |||
| Crystal structure of human MTH1(G2K mutant) in complex with 2-oxo-dATP at pH 7.7 | monomer | 99.35 | 1×6U4; 3×NA; | |||
| Crystal structure of human MTH1(G2K mutant) in complex with 8-oxo-dGTP | monomer | 99.36 | 1×8DG; 2×NA; | |||
| Crystal structure of human MTH1(G2K mutant) in complex with 2-oxo-dAMP and Mn2+ | monomer | 99.36 | 1×IGU; 3×MN; | |||
| Crystal structure of human MTH1(G2K/D120N mutant) in complex with 2-oxo-dATP | monomer | 98.72 | 1×6U4; 2×NA; | |||
| Crystal structure of hMTH1 N33A in complex with LW14 in the presence of acetate | monomer | 99.36 | 1×BU8; 1×SO4; 1×ACT; | |||
| Crystal structure of human MTH1(G2K mutant) in complex with 8-oxo-dGTP at pH 8.6 | monomer | 99.35 | 1×8DG; 4×NA; | |||
| Crystal structure of human MTH1(G2K mutant) in complex with 8-oxo-dGTP at pH 9.1 | monomer | 99.35 | 3×NA; | |||
| Crystal structure of human MTH1(G2K mutant) in complex with 8-oxo-dGMP and Mn2+ | monomer | 99.36 | 1×8OG; 3×MN; | |||
| Crystal structure of human MTH1(G2K/D120N mutant) in complex with 8-oxo-dGTP at pH 6.5 | monomer | 98.72 | 1×8DG; | |||
| Crystal structure of human MTH1(G2K mutant) in complex with 8-oxo-dGTP at pH 8.0 | monomer | 99.36 | 1×8DG; 3×NA; | |||
| Crystal structure of human MTH1(G2K/D120N mutant) in complex with 8-oxo-dGTP at pH 7.0 | monomer | 98.72 | 1×8DG; 1×NA; | |||
| Crystal structure of hMTH1 N33G in complex with TH scaffold 1 in the absence of acetate | monomer | 99.36 | 2×F3E; 4×SO4; | |||
| Complex between MTH1 and compound 29 (a 4-amino-2,7-diazaindole derivative) | monomer | 100 | 1×C9B; 5×SO4; | |||
| Crystal structure of hMTH1 N33G in complex with LW14 in the absence of acetate | monomer | 99.36 | 1×BU8; 4×SO4; | |||
| Crystal structure of hMTH1 N33G in complex with TH scaffold 1 in the presence of acetate | monomer | 99.36 | 2×F3E; 1×ACT; 3×SO4; | |||
| Crystal structure of hMTH1 N33G in the presence of acetate | monomer | 99.36 | 2×SO4; | |||
| Crystal structure of human MTH1 in complex with O6-methyl-dGMP | monomer | 100 | 4×SO4; 1×ACT; 1×6OG; | |||
| Complex between MTH1 and compound 16 (a 4-amino-7-azaindole derivative) | monomer | 100 | 1×C8Z; 5×SO4; 2×GOL; | |||
| Complex between MTH1 and compound 1 (a 7-azaindole-4-ester derivative) | monomer | 100 | 1×C9E; 5×SO4; 2×ACT; | |||
| Solution structure of the hMTH1, a nucleotide pool sanitization enzyme | monomer | 100 | ||||
| Crystal structure of hMTH1 F27A in complex with LW14 in the presence of acetate | monomer | 99.36 | 1×BU8; 1×SO4; 1×ACT; | |||
| Crystal structure of MTH1 in complex with compound 32 | monomer | 100 | 1×ZRV; 2×SO4; | |||
| Potent and selective inhibitors of MTH1 probe its role in cancer cell survival | monomer | 100 | 1×RX8; | |||
| Crystal structure of hMTH1 D120N in complex with TH scaffold 1 in the absence of acetate | monomer | 99.36 | 1×F3E; 4×SO4; | |||
| MTH1 in complex with fragment 4 | monomer | 100 | 1×AX7; 1×SO4; | |||
| Potent and selective inhibitors of MTH1 probe its role in cancer cell survival | monomer | 100 | 1×RJE; | |||
| Crystal structure of MTH1 in complex with compound 31 | monomer | 100 | 1×ZRP; 2×SO4; | |||
| MTH1 in complex with compound 15 | monomer | 100.0 | 1×RGJ; | |||
| Crystal structure of hMTH1 F27A in complex with LW14 in the absence of acetate | monomer | 99.35 | 1×BU8; 2×SO4; | |||
| MTH1 substrate recognition: Complex with a methylaminopurinone | monomer | 100 | 1×UAN; 1×SO4; | |||
| Crystal structure of hMTH1 F27A in complex with TH scaffold 1 in the absence of acetate | monomer | 99.35 | 4×SO4; 1×F3E; | |||
| MTH1 in complex with compound 24 | monomer | 100 | 1×9CQ; | |||
| MTH1 in complex with TH013350 | monomer | 100 | 2×KOX; 1×SO4; | |||
| MTH1 in complex with fragment 8 | monomer | 100 | 1×BSW; 2×SO4; | |||
| Crystal structure of hMTH1 N33A in complex with TH scaffold 1 in the absence of acetate | monomer | 99.35 | 1×F3E; 4×SO4; | |||
| Crystal structure of hMTH1 in complex with TH scaffold 1 in the presence of acetate | monomer | 100 | 1×F3E; 1×SO4; | |||
| MTH1 in complex with compound 4 | monomer | 100 | 1×8JF; | |||
| Crystal structure of hMTH1 N33A in the presence of acetate | monomer | 99.35 | 3×SO4; | |||
| MTH1 in complex with fragment 11 | monomer | 100 | 1×BS8; 1×SO4; | |||
| Crystal structure of human MTH1 in complex with inhibitor 7-(furan-2-yl)-5-methyl-1,3-benzoxazol-2-… | monomer | 100 | 1×8WZ; 2×SO4; | |||
| The Crystal Structure of human MTH1 from Biortus | monomer | 100 | 1×PG4; 1×PEG; | |||
| MTH1 substrate recognition: Complex with 8-oxo-dGTP. | monomer | 100 | 1×H6Y; 1×ACT; | |||
| Crystal structure of hMTH1 D120N in the presence of acetate | monomer | 99.35 | 1×DMS; | |||
| MTH1 in complex with TH013074 | monomer | 100 | 1×KYR; 1×SO4; | |||
| Crystal structure of hMTH1 F27A in complex with TH scaffold 1 in the presence of acetate | monomer | 99.35 | 1×F3E; | |||
| Crystal structure of hMTH1 N33A in complex with LW14 in the absence of acetate | monomer | 99.35 | 1×BU8; 2×SO4; | |||
| Structure of human MTH1 in complex with TH287 | monomer | 100 | 1×2GD; 4×SO4; | |||
| MTH1 substrate recognition: Complex with 8-oxo-dGTP. | monomer | 100 | 1×8DG; | |||
| MTH1 substrate recognition: Complex with a methylbenzimidazolyl acetamide. | monomer | 100 | 1×ACT; 1×N91; 3×DMS; | |||
| MTH1 substrate recognition: Complex with a methylaminopyrimidinedione. | monomer | 100 | 1×ACT; 1×S76; 2×DMS; | |||
| MTH1 substrate recognition: Complex with a aminomethylpyrimidinyl oxypropanol. | monomer | 100 | 1×6Q3; 1×ACT; 1×DMS; | |||
| Crystal structure of hMTH1 D120N in complex with LW14 in the presence of acetate | monomer | 99.35 | 1×BU8; | |||
| BAY-707 in complex with MTH1 | monomer | 100 | 1×8XT; 6×SO4; 1×GOL; | |||
| Crystal structure of human apo MTH1 | monomer | 100 | ||||
| MTH1 in complex with fragment 9 | monomer | 100 | 1×BU5; 1×SO4; | |||
| Crystal structure of human MTH1 in complex with 8-oxo-dGMP | monomer | 100 | 1×8OG; 2×SO4; | |||
| MTH1 in complex with compound 15 | monomer | 100 | 1×DMS; 1×58T; | |||
| Crystal Structure of Human 8-oxo-dGTPase (MTH1) | monomer | 100 | 3×SO4; 1×IMD; 2×GOL; | |||
| MTH1 in complex with compound 5 | monomer | 100 | 1×S3O; | |||
| Crystal structure of human MTH1 in complex with compound MI1030 | monomer | 100 | 1×CJR; | |||
| MTH1 in complex with fragment 6 | monomer | 100 | 1×BU8; | |||
| Crystal structure of human MTH1 in complex with compound MI0639 | monomer | 100 | 1×95F; | |||
| Crystal structure of human MTH1 in complex with inhibitor 6-[(2-phenylethyl)sulfanyl]-7H-purin-2-am… | monomer | 100 | 1×8WW; 6×SO4; 1×ACT; | |||
| MTH1 in complex with TH012532 | monomer | 100 | 1×KLO; 1×GOL; 6×SO4; | |||
| Crystal structure of MTH1 in complex with alpha-mangostin (cocktail No. 9) | monomer | 100 | 2×ZN; 1×MKS; 1×SO4; | |||
| Complex between MTH1 and compound 7 (a 7-azaindole-2-amide derivative) | monomer | 100 | 1×C9Q; 3×SO4; | |||
| Crystal structure of human MTH1 in complex with compound MI1014 | monomer | 100 | 1×CG0; | |||
| Crystal structure of human MTH1 | monomer | 100 | 1×ACT; 3×SO4; | |||
| Crystal structure of MTH1 in complex with 3-isomangostin | monomer | 100 | 1×MKU; 3×ZN; 1×SO4; | |||
| Crystal structure of human MTH1 in complex with compound MI1022 | monomer | 100 | 1×CJ6; | |||
| MTH1 in complex with compound 32 | monomer | 100 | 1×GN6; | |||
| Crystal structure of hMTH1 F27A in the presence of acetate | monomer | 99.35 | ||||
| Crystal structure of MTH1 in apo form (cocktail No. 1) | monomer | 100 | 3×ZN; 1×SO4; | |||
| MTH1 in complex with fragment 1 | monomer | 100 | 1×EV2; 1×ACT; 1×SO4; | |||
| Crystal structure of human MTH1 in complex with compound MI0320 | monomer | 100 | 1×95L; | |||
| Crystal structure of human MTH1 in complex with compound MI1016 | monomer | 100 | 1×CGX; | |||
| Crystal structure of human MTH1 in complex with compound MI1029 | monomer | 100 | 1×CJL; | |||
| Crystal structure of MTH1 in complex with 18-Crown-6 | monomer | 100 | 3×ZN; 1×SO4; 2×O4B; 1×VGH; | |||
| Crystal structure of human MTH1 in complex with compound MI1012 | monomer | 100 | 1×CEU; | |||
| Crystal structure of human MTH1 in complex with compound MI1020 | monomer | 100 | 1×CJ0; | |||
| MTH1 in complex with TH001969 | monomer | 100 | 1×L3N; 3×SO4; | |||
| Crystal structure of human MTH1 in complex with compound MI1025 | monomer | 100 | 1×CJF; | |||
| Crystal structure of human MTH1 in complex with fragment inhibitor 8-(methylsulfanyl)-7H-purin-6-am… | monomer | 100 | 1×8WT; 4×SO4; | |||
| Crystal structure of human MTH1 in complex with compound MI1024 | monomer | 100 | 1×CJ9; | |||
| Crystal structure of human MTH1 in complex with compound MI0861 | monomer | 100 | 1×95R; 1×SO4; | |||
| Crystal structure of human MTH1 in complex with compound MI1026 | monomer | 100 | 1×CJU; | |||
| Crystal structure of human MTH1 in complex with compound MI1006 | monomer | 100 | 1×C9L; | |||
| Crystal structure of human MTH1 in complex with N6-methyl-dAMP | monomer | 100 | 3×SO4; 1×6MA; | |||
| MTH1 in complex with Ruthenium-based inhibitor | monomer | 100 | 3×SO4; 1×RUX; | |||
| Crystal structure of hMTH1 N33G in complex with LW14 in the presence of acetate | monomer | 99.35 | 1×BU8; 2×SO4; 1×ACT; | |||
| Structure of human MTH1 in complex with TH588 | monomer | 100 | 1×2GE; 7×SO4; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3q93.1.A | monomer | 0.89 | 1×IMD; | 100.00 | ||